Their analysis suggested that miR-137 inhibited EC by supressing cell proliferation and targeting elevated polycomb group protein enhancer of zeste homolog 2 (EZH2) and lysine-specific histone demethylase 1 (LSD1) proteins, therefore, acting as a tumor suppressor agent. The gene discussed is KDM1A; the disease is neoplasm.